Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.
Wolpin BM; Hezel AF; Abrams T; Blaszkowsky LS; Meyerhardt JA; Chan JA; Enzinger PC; Allen B; Clark JW; Ryan DP; Fuchs CS; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2009, vol. 27, issue 2, p 193, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef